Cloopen Enters into Definitive Merger Agreement for Going-Private Transaction

This is a straightforward, long-dated going-private deal with limited near-term upside.

Risk flags

• ●Execution risk is high due to the long timeline: the merger is not expected to close until the fourth quarter of 2026, leaving significant time for market, regulatory, or shareholder dynamics to shift. Delays or deal failure could leave investors exposed to downside if the company’s fundamentals are weak.
• ●The majority of claims are forward-looking and contingent on approvals: the cash payout and going-private outcome depend on a two-thirds shareholder vote and regulatory sign-off, neither of which is guaranteed. If these are not secured, the deal will not proceed.
• ●There is a complete lack of operational or financial disclosure: no revenue, profit, cash flow, or balance sheet data is provided, making it impossible for investors to assess the company’s underlying health or the fairness of the offer. This opacity is a material risk, especially in a take-private scenario.
• ●Insider control is significant: the buyer group, led by the founder and CEO, already controls 57.25% of voting power. While this increases deal certainty, it raises concerns about process independence and whether minority shareholders are receiving full value.
• ●Capital intensity is high: the deal implies an equity value of US$162.89 million and requires a US$42 million debt facility. If the deal fails, the company’s ability to service or refinance debt, or to operate independently, is unclear.
• ●Geographic and regulatory risk is present: the company and key parties are based in China, and the transaction is governed by Cayman Islands law. Cross-border deals in this region can face unpredictable regulatory or political hurdles, which are not addressed in the announcement.
• ●No details are provided on the strategic rationale or post-merger plans: investors have no visibility into what the buyer group intends to do with the company, or whether there is a risk of asset stripping, restructuring, or other adverse outcomes post-transaction.
• ●The absence of a definitive closing date and the reliance on future approvals mean that the premium offered is not locked in. Market conditions or buyer group intentions could change before closing, potentially jeopardizing the deal.

Bottom line

For investors, this announcement means that Cloopen Group Holding Limited (OTC: RAASY) is set to be acquired and taken private at a substantial premium to recent trading prices, but only if the deal closes as planned in late 2026. The offer is backed by a credible buyer group, including the founder/CEO and several institutional investors, and funding appears to be in place via a US$42 million debt commitment. However, the lack of any operational or financial performance data leaves investors in the dark about whether the premium is justified or if the company is being sold cheaply. The process is heavily controlled by insiders, which may expedite approval but also raises questions about fairness to minority holders. There is no information on what will happen to the business post-merger, nor any discussion of strategic rationale or future value creation. To change this assessment, the company would need to disclose detailed financials, rationale for the transaction, and evidence of regulatory or shareholder approvals already secured. Investors should watch for updates on the shareholder vote, regulatory filings, and any changes to the closing timeline. Given the long execution window and the lack of transparency, this is a situation to monitor rather than act on immediately. The single most important takeaway is that while the headline premium is attractive, the deal is far from certain and the absence of financial disclosure is a major red flag.

Announcement summary

Cloopen Group Holding Limited (OTC: RAASY) announced it has entered into a definitive Agreement and Plan of Merger with SpringX Holdings Limited and AutumnX Holdings Limited, under which Cloopen will be acquired by a consortium (the Buyer Group) in a transaction implying an equity value of approximately US$162.89 million. Shareholders will receive US$0.4940 in cash per ordinary share or US$2.9641 in cash per ADS, representing premiums of 51.23% and 110.22% to recent closing prices. The Buyer Group currently owns about 28.42% of shares and 57.25% of voting power. The Merger is expected to close in the fourth quarter of 2026, subject to shareholder and regulatory approvals, and will result in Cloopen becoming a privately-owned company.

Disagree with this article?